Somer L Smith1, Ann M Chahroudi1, Andres F Camacho-Gonzalez1, Scott Gillespie2, Bridget A Wynn1, Martina L Badell3, Andrea Swartzendruber4, Rohan Hazra5, Pascale Wortley6, Rana Chakraborty1. 1. Division of Pediatric Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia. 2. Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia. 3. Division of Maternal-Fetal Medicine, Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia. 4. Department of Behavioral Sciences and Health Education, Emory University Rollins School of Public Health, Atlanta, Georgia. 5. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Bethesda, Maryland. 6. HIV Epidemiology Section, Georgia Department of Public Health, Atlanta.
Abstract
OBJECTIVE: Our goal was to evaluate the infrastructure of programs for the prevention of mother-to-child transmission (PMTCT) of human immunodeficiency virus (HIV) in major delivery units in the Atlanta, Georgia, metropolitan statistical area and to assess the knowledge, attitude, and practice of providers in these facilities around PMTCT. METHODS: Hospital assessments and individual knowledge and practices were surveyed among 71 healthcare providers from March 2015 to March 2016 in 11 hospitals that deliver 40000 infants annually, which represents 70% of all deliveries in the Atlanta metropolitan statistical area. Included were questions about HIV testing for mother-infant pairs, test result turnaround times, policies and procedures for PMTCT, opt-out versus opt-in testing, availability of rapid point-of-care testing on labor and delivery units, and postnatal prophylaxis. RESULTS: Seventy-three percent (8 of 11) of the hospitals had limitations in their PMTCT infrastructure, and 36% (4 of 11) reported no standardized policies for care of HIV-infected women. Three labor and delivery units used opt-in HIV testing of women. Only 27% (3 of 11) of the hospitals reported nucleic acid testing of HIV-exposed infants. Oral zidovudine for infant prophylaxis was available in all the hospitals, but 64% (7 of 11) of them did not stock nevirapine. Fifty-nine percent (24 of 44) of the obstetricians did not routinely offer rapid testing at delivery without a third-trimester HIV test, and 78% (n = 32 of 41) of them did not offer testing at delivery if the woman declined antenatal testing. The facility with the most annual births in Georgia did not offer rapid testing at delivery for women with an unknown HIV status. CONCLUSION: We identified several limitations in PMTCT infrastructure that might have contributed to perinatal HIV transmissions. The need to address these healthcare gaps to eliminate mother-to-child transmission of HIV in the United States is urgent.
OBJECTIVE: Our goal was to evaluate the infrastructure of programs for the prevention of mother-to-child transmission (PMTCT) of human immunodeficiency virus (HIV) in major delivery units in the Atlanta, Georgia, metropolitan statistical area and to assess the knowledge, attitude, and practice of providers in these facilities around PMTCT. METHODS: Hospital assessments and individual knowledge and practices were surveyed among 71 healthcare providers from March 2015 to March 2016 in 11 hospitals that deliver 40000 infants annually, which represents 70% of all deliveries in the Atlanta metropolitan statistical area. Included were questions about HIV testing for mother-infant pairs, test result turnaround times, policies and procedures for PMTCT, opt-out versus opt-in testing, availability of rapid point-of-care testing on labor and delivery units, and postnatal prophylaxis. RESULTS: Seventy-three percent (8 of 11) of the hospitals had limitations in their PMTCT infrastructure, and 36% (4 of 11) reported no standardized policies for care of HIV-infected women. Three labor and delivery units used opt-in HIV testing of women. Only 27% (3 of 11) of the hospitals reported nucleic acid testing of HIV-exposed infants. Oral zidovudine for infant prophylaxis was available in all the hospitals, but 64% (7 of 11) of them did not stock nevirapine. Fifty-nine percent (24 of 44) of the obstetricians did not routinely offer rapid testing at delivery without a third-trimester HIV test, and 78% (n = 32 of 41) of them did not offer testing at delivery if the woman declined antenatal testing. The facility with the most annual births in Georgia did not offer rapid testing at delivery for women with an unknown HIV status. CONCLUSION: We identified several limitations in PMTCT infrastructure that might have contributed to perinatal HIV transmissions. The need to address these healthcare gaps to eliminate mother-to-child transmission of HIV in the United States is urgent.
Authors: Suzanne K Whitmore; Allan W Taylor; Lorena Espinoza; R Luke Shouse; Margaret A Lampe; Steven Nesheim Journal: Pediatrics Date: 2011-12-05 Impact factor: 7.124
Authors: Allan W Taylor; Steven R Nesheim; Xinjian Zhang; Ruiguang Song; Lauren F FitzHarris; Margaret A Lampe; Paul J Weidle; Patricia Sweeney Journal: JAMA Pediatr Date: 2017-05-01 Impact factor: 16.193
Authors: Claire L Townsend; Laura Byrne; Mario Cortina-Borja; Claire Thorne; Annemiek de Ruiter; Hermione Lyall; Graham P Taylor; Catherine S Peckham; Pat A Tookey Journal: AIDS Date: 2014-04-24 Impact factor: 4.177
Authors: E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson Journal: N Engl J Med Date: 1994-11-03 Impact factor: 91.245
Authors: Steven Nesheim; Allan Taylor; Margaret A Lampe; Peter H Kilmarx; Lauren Fitz Harris; Suzanne Whitmore; Judy Griffith; Melissa Thomas-Proctor; Kevin Fenton; Jonathan Mermin Journal: Pediatrics Date: 2012-09-03 Impact factor: 7.124
Authors: Gabriela Del Bianco; Cynthia S Bell; Laura J Benjamins; Norma Pérez; Gilhen Rodriguez; James R Murphy; Gloria P Heresi Journal: Pediatr Infect Dis J Date: 2014-06 Impact factor: 2.129
Authors: Andrea L Ciaranello; Freddy Perez; Jo Keatinge; Ji-Eun Park; Barbara Engelsmann; Matthews Maruva; Rochelle P Walensky; Francois Dabis; Jennifer Chu; Asinath Rusibamayila; Angela Mushavi; Kenneth A Freedberg Journal: PLoS Med Date: 2012-01-10 Impact factor: 11.069
Authors: Andres F Camacho-Gonzalez; Marie-Huguette Kingbo; Ashley Boylan; Allison Ross Eckard; Ann Chahroudi; Rana Chakraborty Journal: AIDS Date: 2015-07-31 Impact factor: 4.177